Cargando…

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents

Today, personalized cancer therapy with targeted agents has taken center stage, and offers individualized treatment to many. As the mysteries of the genes in a cell's DNA and their specific proteins are defined, advances in the understanding of cancer gene mutations and how cancer evades the im...

Descripción completa

Detalles Bibliográficos
Autor principal: Wilkes, Gail M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863423/
https://www.ncbi.nlm.nih.gov/pubmed/29607374
http://dx.doi.org/10.4103/apjon.apjon_79_17
_version_ 1783308386151956480
author Wilkes, Gail M.
author_facet Wilkes, Gail M.
author_sort Wilkes, Gail M.
collection PubMed
description Today, personalized cancer therapy with targeted agents has taken center stage, and offers individualized treatment to many. As the mysteries of the genes in a cell's DNA and their specific proteins are defined, advances in the understanding of cancer gene mutations and how cancer evades the immune system have been made. This article provides a basic and simplified understanding of the available (Food and Drug Administration- approved) molecularly and immunologically targeted agents in the USA. Other agents may be available in Asia, and throughout the USA and the world, many more agents are being studied. Nursing implications for drug classes are reviewed.
format Online
Article
Text
id pubmed-5863423
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58634232018-04-01 Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents Wilkes, Gail M. Asia Pac J Oncol Nurs Review Article Today, personalized cancer therapy with targeted agents has taken center stage, and offers individualized treatment to many. As the mysteries of the genes in a cell's DNA and their specific proteins are defined, advances in the understanding of cancer gene mutations and how cancer evades the immune system have been made. This article provides a basic and simplified understanding of the available (Food and Drug Administration- approved) molecularly and immunologically targeted agents in the USA. Other agents may be available in Asia, and throughout the USA and the world, many more agents are being studied. Nursing implications for drug classes are reviewed. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5863423/ /pubmed/29607374 http://dx.doi.org/10.4103/apjon.apjon_79_17 Text en Copyright: © 2018 Ann & Joshua Medical Publishing Co. Ltd http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Wilkes, Gail M.
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title_full Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title_fullStr Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title_full_unstemmed Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title_short Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
title_sort targeted therapy: attacking cancer with molecular and immunological targeted agents
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863423/
https://www.ncbi.nlm.nih.gov/pubmed/29607374
http://dx.doi.org/10.4103/apjon.apjon_79_17
work_keys_str_mv AT wilkesgailm targetedtherapyattackingcancerwithmolecularandimmunologicaltargetedagents